Listen

Description

The Journal of Rheumatology's Editor-in-Chief Earl Silverman talks about this month's selection of articles that are most relevant to the clinical rheumatologist.

This month’s selections include:

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial by Karen Hambardzumyan, Rebecca J. Bolce, Johan K. Wallman, Ronald F. van Vollenhoven and Saedis Saevarsdottir DOI: https://doi.org/10.3899/jrheum.180537

Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial by Arthur Kavanaugh, M. Elaine Husni, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Lenore Noonan and Elizabeth C. Hsia DOI: https://doi.org/10.3899/jrheum.180681

Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy by Océane Landon-Cardinal, Yves Allenbach, Antoine Soulages, Aude Rigolet, Baptiste Hervier, Nicolas Champtiaux, Quentin Monzani, Guilhem Solé and Olivier Benveniste DOI: https://doi.org/10.3899/jrheum.171495

Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort by Jaime Guzman, Andrew Henrey, Thomas Loughin, Roberta A. Berard, Natalie J. Shiff, Roman Jurencak, Adam M. Huber, Kiem Oen, Kerstin Gerhold, Brian M. Feldman, Rosie Scuccimarri, Kristin Houghton, Gaëlle Chédeville, Kimberly Morishita, Bianca Lang, Paul Dancey, Alan M. Rosenberg, Julie Barsalou, Alessandra Bruns, Karen Watanabe Duffy, Susanne Benseler, Ciaran M. Duffy, Lori B. Tucker and the ReACCh-Out Investigators DOI: https://doi.org/10.3899/jrheum.180456